SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-10-01
👔
RESMED INC
@RMD_InsiderForm 4 Filing: Bloomer Aaron Acquires (Grant) shares of $RMD
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
RESMED INC
Ticker: $RMD
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-08-14
Shares: 9,072
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Bloomer Aaron, holds the title of Chief Financial Officer at RESMED INC.
On 2026-08-14, the insider transacted 9,072 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Bloomer Aaron (Chief Financial Officer) was granted $0 of $RMD
Post-Transaction Position: 9,072 shares
SEC Accession No: 0000943819-26-000073 (CIK: 2019003)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.